Skip to main content

Nabla

Category: AI in Healthcare

An ambient AI assistant for healthcare practitioners that generates clinical notes from patient consultations to reduce administrative burden. Nabla was founded in 2018. The company is led by Brian Manning. Based in New York, United States (with Paris office). Team size: N/A. Total funding raised: $120M. Latest round: Series C. Key investors include HV Capital, Highland Europe, DST Global, Cathay Innovation, Build Collective, Radical Ventures.

Founded
2018
Headquarters
New York, United States (with Paris office)
Team size
N/A
Total funding
$120M

Value proposition

To reduce clinician burnout and improve patient care by automating the generation of clinical documentation, allowing doctors to focus on patients rather than paperwork.

Products and solutions

Nabla Copilot, Nabla Dictation for Mac

Unique value

Nabla was developed through a unique approach of co-creation with a community of thousands of clinicians. The company emphasizes its focus on improving clinicians' quality of life over purely revenue-cycle management and boasts high accuracy in creating concise notes that filter out non-medical conversation.

Target customer

Healthcare providers, including individual clinicians, physician groups, academic medical centers, and large health systems.

Industries served

Healthcare

Technology advantage

The founding team's deep expertise in AI from Meta's research division provides a strong technical foundation. The platform is designed for ease of use, requiring no special training, and integrates with major EHR systems like Epic and Nextgen. Its business advantage is demonstrated by rapid user adoption and large-scale partnerships.

How they differentiate

Nabla differentiates itself through its speed, accuracy, and user-centric design focused on reducing practitioner burnout. Unlike some competitors that prioritize revenue cycle management, Nabla's primary goal is to improve the clinical workflow and restore the joy of practicing medicine.

Main competitors

Suki, Abridge, Nuance (Microsoft)

Key partnerships

The Permanente Medical Group, Catalight, Neighborhood Healthcare, AstraZeneca, Bristol Myers Squibb, Takeda, Advanced Machine Intelligence (AMI)

Notable customers

The Permanente Medical Group, Catalight, Neighborhood Healthcare, CVS Health, M Health Fairview, UCLA Health, University of Iowa Health Care

Major milestones

Launch of Nabla Copilot in March 2023., Partnership with The Permanente Medical Group to roll out the tool to 10,000 doctors in October 2023., Raised $24M in Series B funding in January 2024., Raised $70M in Series C funding in June 2025.

Growth metrics

Supports more than 190 healthcare organizations, 100,000 clinicians, and 40 million patient encounters annually.

Market positioning

Positioned as a leading and rapidly growing ambient AI assistant for healthcare, with significant traction in the U.S. and European markets.

Geographic focus

United States, Europe

Patents and IP

Not publicly disclosed.

About Brian Manning

Brian Manning most recently served as President and Chief Revenue Officer of Bamboo Health, helping scale it to more than $140M in ARR and over 300 employees. Previously, he was an early PatientPing employee who built its go-to-market organization through its acquisition, and helped establish Zocdoc’s enterprise sales organization.

Latest news about Nabla

More AI in Healthcare companies

Official website: